Ameritas Investment Partners’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.2M | Buy |
4,152
+22
| +0.5% | +$10.2K | 0.06% | 345 |
|
|
2026
Q1 | $1.98M | Buy |
4,130
+52
| +1% | +$26.6K | 0.06% | 348 |
|
|
2025
Q4 | $2.29M | Sell |
4,078
-82
| -2% | -$46.5K | 0.07% | 292 |
|
|
2025
Q3 | $2.14M | Sell |
4,160
-416
| -9% | -$182K | 0.07% | 311 |
|
|
2025
Q2 | $1.44M | Sell |
4,576
-340
| -7% | -$102K | 0.05% | 473 |
|
|
2025
Q1 | $1.5M | Sell |
4,916
-189
| -4% | -$63.6K | 0.05% | 440 |
|
|
2024
Q4 | $1.7M | Sell |
5,105
-111
| -2% | -$37.6K | 0.06% | 405 |
|
|
2024
Q3 | $1.74M | Buy |
5,216
+208
| +4% | +$79K | 0.06% | 400 |
|
|
2024
Q2 | $2.06M | Sell |
5,008
-141
| -3% | -$55.8K | 0.07% | 285 |
|
|
2024
Q1 | $2.08M | Hold |
5,149
| – | – | 0.07% | 324 |
|
|
2023
Q4 | $1.58M | Sell |
5,149
-60
| -1% | -$16.2K | 0.06% | 409 |
|
|
2023
Q3 | $1.26M | Sell |
5,209
-960
| -16% | -$246K | 0.05% | 460 |
|
|
2023
Q2 | $1.48M | Sell |
6,169
-2,326
| -27% | -$483K | 0.06% | 423 |
|
|
2023
Q1 | $1.6M | Buy |
8,495
+48
| +0.6% | +$9.93K | 0.06% | 380 |
|
|
2022
Q4 | $2.02M | Hold |
8,447
| – | – | 0.08% | 287 |
|
|
2022
Q3 | $1.33M | Sell |
8,447
-798
| -9% | -$127K | 0.06% | 398 |
|
|
2022
Q2 | $1.38M | Sell |
9,245
-710
| -7% | -$103K | 0.06% | 405 |
|
|
2022
Q1 | $1.63M | Hold |
9,955
| – | – | 0.06% | 405 |
|
|
2021
Q4 | $2.17M | Buy |
9,955
+143
| +1% | +$29.9K | 0.07% | 302 |
|
|
2021
Q3 | $1.86M | Sell |
9,812
-28
| -0.3% | -$5.11K | 0.07% | 332 |
|
|
2021
Q2 | $1.74M | Buy |
9,840
+50
| +0.5% | +$8.63K | 0.06% | 374 |
|
|
2021
Q1 | $1.61M | Sell |
9,790
-242
| -2% | -$37K | 0.06% | 380 |
|
|
2020
Q4 | $1.4M | Sell |
10,032
-69
| -0.7% | -$8.7K | 0.06% | 396 |
|
|
2020
Q3 | $1.13M | Buy |
10,101
+7,719
| +324% | +$893K | 0.05% | 417 |
|
|
2020
Q2 | $222K | Sell |
2,382
-85
| -3% | -$7.23K | 0.01% | 967 |
|
|
2020
Q1 | $181K | Buy |
2,467
+104
| +4% | +$9.03K | 0.01% | 982 |
|
|
2019
Q4 | $199K | Hold |
2,363
| – | – | 0.01% | 1088 |
|
|
2019
Q3 | $199K | Hold |
2,363
| – | – | 0.01% | 1054 |
|
|
2019
Q2 | $155K | Buy |
2,363
+555
| +31% | +$32K | 0.01% | 1219 |
|
|
2019
Q1 | $107K | Hold |
1,808
| – | – | 0.01% | 1433 |
|
|
2018
Q4 | $96K | Hold |
1,808
| – | – | 0.01% | 1411 |
|
|
2018
Q3 | $108K | Buy |
1,808
+795
| +78% | +$43.5K | 0.01% | 1510 |
|
|
2018
Q2 | $44K | Buy |
1,013
+325
| +47% | +$13.1K | ﹤0.01% | 2073 |
|
|
2018
Q1 | $24K | Hold |
688
| – | – | ﹤0.01% | 2328 |
|
|
2017
Q4 | $25K | Hold |
688
| – | – | ﹤0.01% | 2329 |
|
|
2017
Q3 | $22K | Hold |
688
| – | – | ﹤0.01% | 2374 |
|
|
2017
Q2 | $20K | Hold |
688
| – | – | ﹤0.01% | 2450 |
|
|
2017
Q1 | $21K | Buy |
+688
| New | +$22.2K | ﹤0.01% | 2377 |
|
Other funds holding MEDP
Ameritas Investment Partners's MEDP Position: Q2 2026 in Review
Ameritas Investment Partners increased its Medpace (MEDP) stake by 0.53% in Q2 2026, buying an estimated $10.2K and bringing the position to 4,152 shares worth $2.2M. The position accounts for 0.06% of the portfolio, ranked #345.
Ameritas Investment Partners first reported a position in MEDP in Q1 2017 and has held it in 38 quarters since. The position peaked at $2.29M in Q4 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Ameritas Investment Partners held 4,152 shares of Medpace worth $2.2M as of Q2 2026.
- Ameritas Investment Partners bought 22 Medpace shares in Q2 2026, an estimated $10.2K.
- Medpace made up 0.06% of Ameritas Investment Partners's portfolio in Q2 2026, its #345 holding.
- Ameritas Investment Partners first reported a position in Medpace in Q1 2017 and has held it in 38 quarters since.
- Ameritas Investment Partners's Medpace position peaked at $2.29M in Q4 2025.
- 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.